Marketing-authorisation holder · Spain
Takeda Farmaceutica Espana S.A.
8 medicines in 1 country, as authorisation holder and marketer.
Loading your page…
Loading your page…
Marketing-authorisation holder · Spain
8 medicines in 1 country, as authorisation holder and marketer.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
8 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| BEMOLAN 2000 mg GEL ORAL2000 mg · Gel oral | Magaldrate | Spain | Marketed | 1995 |
| BEMOLAN 800 mg GEL ORAL800 mg · Gel oral | Magaldrate | Spain | Marketed | 1987 |
| OPIREN 15 mg CAPSULAS15 mg · Cápsula dura gastrorresistente | Lansoprazole | Spain | Marketed | 1997 |
| OPIREN 30 mg CAPSULAS30 mg · Cápsula dura gastrorresistente | Lansoprazole | Spain | Marketed | 1993 |
| OPIREN FLAS 15 mg COMPRIMIDOS BUCODISPERSABLES15,0 mg · Comprimido bucodispersable | Lansoprazole | Spain | Marketed | 2003 |
| OPIREN FLAS 30 mg COMPRIMIDOS BUCODISPERSABLES30,0 mg · Comprimido bucodispersable | Lansoprazole | Spain | Marketed | 2003 |
| BOSPORON 8 mg COMPRIMIDOS RECUBIERTOS CON PELICULA8 mg · Comprimido recubierto con película | Lornoxicam | Spain | Withdrawn | 1999 |
| BOSPORON RAPID 8 mg COMPRIMIDOS RECUBIERTOS CON PELICULA8 mg · Comprimido recubierto con película | Lornoxicam | Spain | Withdrawn | 2004 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 8 | 6 | 2 | CompaniesAll medicines |
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.